Cassava CEO, ‘dazed and confused,’ takes to biotech defense handbook by blaming short sellers for woes
The Cassava saga continues as chief Remi Barbier has come out, guns blazing, against accusations that the biotech may have deliberately misdirected investors on a recent Alzheimer’s disease readout.